Next Generation Probiotics Market Size to Exceed USD 485.7 Mn by 2032

The Next Generation Probiotics Market, estimated at USD 231.0 Mn in 2025, is expected to exhibit a CAGR of 11.2% and reach USD 485.7 Mn by 2032.

The market growth is driven by increasing demand for innovative and effective drugs across diverse therapeutic areas. Advances in drug discovery, biopharmaceuticals, and digital technologies are improving treatment outcomes and operational efficiency. Supportive regulations, rising R&D investments, and a strong focus on patient-centric care are creating new opportunities for pharmaceutical companies.

The increasing prevalence of obesity is expected to drive the growth of global next generation probiotics market over the forecast period. For instance, according to the data published by the Centers for Disease Control and Prevention on May 17, 2025, the obesity prevalence was 39.8% among adults aged 20 to 39 years, 44.3% among adults aged 40 to 59 years, and 41.5% among adults aged 60 and older during 2025–March 2025.

Global Next Generation Probiotics Market– Impact of Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic and lockdowns in various countries across the globe have impacted the financial status of businesses across all sectors, including the private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry, mainly due to strict lockdown in several regions. Private healthcare is one such sector that has been impacted significantly by the COVID-19 pandemic.

Global Next Generation Probiotics Market: Key Developments

In January 2025, Winclove Probiotics, a producer and developer of probiotic food supplements, developed Novobiome, a new platform to bring human-derived, next-generation probiotics (NGPs) to the European market. The company aims to generate €8 million (US$ 9.8 million) in turnover within the first five years of commercializing Novobiome. The Novobiome platform aims to resolve the most daunting obstacles to NGP product development and commercialization on the market.

In May 2025, Exeliom Biosciences, a pharmaceutical manufacturing company, announced the opening of a new pilot manufacturing unit for Live Biotherapeutics (LBPs) to boost the company’s research and development. An amount of US$ 2.8 million was granted by the European Innovation Council and SMEs Executive Agency (EISMEA)'s H2020 Accelerator Program to support the set up of this state-of-the-art pilot unit.

Browse 32 Market Data Tables and 26 Figures spread through 178 Pages and in-depth TOC on “Global Next Generation Probiotics Market”- Forecast to 2032, Global Next Generation Probiotics Market, by Bacterial Candidate (Akkermansia, Clostridium species, Bifidobacterium species, Lactobacillus species, and Others (Faecalibacterium, Christensenella,etc.)), by Application (Weight Management, Glucose Management, Inflammatory Bowel Diseases, and Others (Obesity, Metabolic Diseases, etc.)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/next-generation-probiotics-market-5468

Moreover, increasing prevalence of IBD (Inflammatory Bowel Disease) is expected to drive the market growth over the forecast period. For instance, according to the data published by BioMed Central Ltd. in May 2025, increasing trend in the prevalence of IBD (Inflammatory bowel disease) from 2025 to 2025 and from 2025 to 2035 in Iran, notably, shifted from 23 thousand cases in 2025 to about 30 thousand cases in 2025 and it will be increased to about 69 thousand cases in 2035.

Key Takeaways of the Global Next Generation Probiotics Market:

The global next generation probiotics is expected to exhibit a CAGR of 11.2% during the forecast period due to the rising awareness of next generation probiotics. For instance, in August 2025, SRM University, one of the top ranking universities in India, in association with the Gut Microbiota and Probiotic Science Foundation (India), organised its first-ever “Probiotics Awareness Day” in Sonipat. Students from 15 leading schools participated in this unique competition by sharing interesting presentations on the health benefits of Probiotics.
Among bacterial candidate, Lactobacillus species segment is estimated to hold a dominant position in the global next generation probiotics over the forecast period, owing to increasing focus of government bodies to develop next generation probiotics. For instance, on February 11, 2025, Ministry of Science & Technology, a team of Indian Scientists has recently identified the next-generation probiotic bacterium Lactobacillus Plantarum JBC5 from a dairy product that showed great promise in promoting healthy aging. The team has also developed a yogurt using this probiotic bacterium which can be consumed to derive all these health benefits. Scientists discovered the next-generation probiotic bacterium Lactobacillus Plantarum JBC5 from a dairy product that shows great promise in promoting healthy aging on a model organism called Caenorhabditis Elegansa free-living, transparent nematode living temperate soil environments.
Among regions, North America is estimated to account for the largest market share in the global next generation probiotics over the forecast period, owing to increasing inorganic growth strategies by market key players in the region. For instance, on August 6, 2025, Sun Genomics, a microbiome health company, and NZMP, the ingredient solutions brand of global dairy company Fonterra, expanded their existing partnership to better understand various health benefits of probiotics.
Major players operating in the global next generation probiotics include Pendulum, Amsterdam Winclove Probiotics, Metabogen AB (Biogaia), Exeliom Biosciences, TargEDys, Chr. Hansen Holding A/S, YSOPIA Bioscience, A-Mansia Biotech, Next Gen Probiotics, Evolve Biosystems, and DuPont de Nemours, Inc.